Abstract
Purpose: The purpose of this study was to evaluate the macular and retinal nerve fiber layer (RNFL) thickness, and the electrical activity of the macula in patients with Alzheimer’s disease (AD). Material and methods: 30 patients with AD and 30 age and sex matched healthy controls were studied. The thickness and the electrical activity of the macula were evaluated by means of optical coherence tomography (OCT) and multifocal-electroretinogram (mf-ERG). Results: Visual acuity, as well as visual fields and colour vision testing of all patients were normal. However, the mean foveal thickness was 148.50 μm (vs 171.50 μm in the control group, p=0.001) and the RNFL thickness was 104.5 μm in the superior area (vs 123 μm in the control group, p<0.0001) and 116.5 μm in the inferior area (vs 138 μm in the control group, p<0.0001) around the optic nerve. The mean P1 response density amplitude of the foveal area was 146.50 nV/deg2 (vs 293 nV/deg2 in the control group, p<0.0001) and the perifoveal area was 56.60 nV/deg2 (vs 81.50nv/deg2 in the control group, p<0.001). Conclusion: Our study showed that in patients with AD, even without visual failure there was a decrease in macular and RNFL thickness, as well as a decrease of the electrical activity of the macula.
Keywords: Alzheimer, eye, impairment, mfERG, OCT, visual, cone photoreceptors cells, retinal cells.
Current Alzheimer Research
Title:Structural and Functional Impairment of the Retina and Optic Nerve in Alzheimer’s Disease
Volume: 9 Issue: 7
Author(s): Marilita M Moschos, Ioannis Markopoulos, Irini Chatziralli, Alexandros Rouvas, Sokratis G Papageorgiou, Ioannis Ladas and Dimitrios Vassilopoulos
Affiliation:
Keywords: Alzheimer, eye, impairment, mfERG, OCT, visual, cone photoreceptors cells, retinal cells.
Abstract: Purpose: The purpose of this study was to evaluate the macular and retinal nerve fiber layer (RNFL) thickness, and the electrical activity of the macula in patients with Alzheimer’s disease (AD). Material and methods: 30 patients with AD and 30 age and sex matched healthy controls were studied. The thickness and the electrical activity of the macula were evaluated by means of optical coherence tomography (OCT) and multifocal-electroretinogram (mf-ERG). Results: Visual acuity, as well as visual fields and colour vision testing of all patients were normal. However, the mean foveal thickness was 148.50 μm (vs 171.50 μm in the control group, p=0.001) and the RNFL thickness was 104.5 μm in the superior area (vs 123 μm in the control group, p<0.0001) and 116.5 μm in the inferior area (vs 138 μm in the control group, p<0.0001) around the optic nerve. The mean P1 response density amplitude of the foveal area was 146.50 nV/deg2 (vs 293 nV/deg2 in the control group, p<0.0001) and the perifoveal area was 56.60 nV/deg2 (vs 81.50nv/deg2 in the control group, p<0.001). Conclusion: Our study showed that in patients with AD, even without visual failure there was a decrease in macular and RNFL thickness, as well as a decrease of the electrical activity of the macula.
Export Options
About this article
Cite this article as:
M Moschos Marilita, Markopoulos Ioannis, Chatziralli Irini, Rouvas Alexandros, G Papageorgiou Sokratis, Ladas Ioannis and Vassilopoulos Dimitrios, Structural and Functional Impairment of the Retina and Optic Nerve in Alzheimer’s Disease, Current Alzheimer Research 2012; 9 (7) . https://dx.doi.org/10.2174/156720512802455340
DOI https://dx.doi.org/10.2174/156720512802455340 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
HIV-1, Methamphetamine and Astrocyte Glutamate Regulation: Combined Excitotoxic Implications for Neuro-AIDS
Current HIV Research Pharmacology of Rhein and Advancement in the Synthesis of Its Derivatives
Current Traditional Medicine Preface [Hot Topic:Inflammatory Markers and Mediators: Emerging Therapeutic Targets in Diabetes, Cardiovascular and Metabolic Disorders (Guest Editor: Samuel Dagogo-Jack, MD)].
Current Drug Targets Evaluation of Insulin Resistance Induced Brain Tissue Dysfunction in Obese Dams and their Neonates: Role of Ipriflavone Amelioration
Combinatorial Chemistry & High Throughput Screening COVID-19: A Great Mime or a Trigger Event of Autoimmune Manifestations?
Current Rheumatology Reviews Inflammatory Risk Factors and Pathologies Associated with Alzheimers Disease
Current Alzheimer Research Protein Interaction Studies for Understanding the Tremor Pathway in Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets Aging - How Lifestyle Changes Could Prove to be an Effective Medicine for the Aging Cardiovascular System
Current Cardiology Reviews Stem Cells in Amyotrophic Lateral Sclerosis: Motor Neuron Protection or Replacement?
CNS & Neurological Disorders - Drug Targets Perspectives on Therapeutic Target for Multiple System Atrophy
Recent Patents on Regenerative Medicine Past and Recent Progress of Molecular Imaging Probes for β-Amyloid Plaques in the Brain
Current Medicinal Chemistry Neuroinflamm-Aging and Neurodegenerative Diseases: An Overview
CNS & Neurological Disorders - Drug Targets The Effect of Alkaloid Extracted from <i>Huperzia Phlegmaria</i> on Cognitive Deficits Scopolamine-Induced in Mice
Current Bioactive Compounds Markers of Atherosclerotic Disease: What do they Mean? Current Opinion and Future Trends
Current Pharmaceutical Design Is Human Immunodeficiency Virus-Mediated Dementia an Autophagic Defect that Leads to Neurodegeneration?
CNS & Neurological Disorders - Drug Targets Ectonucleotidases and Nucleotide/Nucleoside Transporters as Pharmacological Targets for Neurological Disorders
CNS & Neurological Disorders - Drug Targets Psychotic (Delusional) Major Depression in the Elderly: A Review
Current Psychiatry Reviews Inhibition of Protein Misfolding and Aggregation by Small Rationally-Designed Peptides
Current Pharmaceutical Design Alzheimer’s Disease: New Concepts on the Role of Autoimmunity and NLRP3 Inflammasome in the Pathogenesis of the Disease
Current Neuropharmacology Current Opinions and Perspectives on the Role of Immune System in the Pathogenesis of Parkinson's Disease
Current Pharmaceutical Design